Abstracts

EBV: IMMUNOPATHOGENESIS AND THE PATH TO AN EBV VACCINE

EBV is the principal cause of infectious mononucleosis and is associated with about 2,000 new cases of cancer worldwide each year, including epithelial cell malignancies such as gastric and nasopharyngeal carcinoma, and B cell lymphomas. EBV is associated with several malignancies in patients with HIV including Burkitt lymphoma, Hodgkin lymphoma, diffuse large B cell lymphoma,…

UPDATE ON ANTIRETROVIRAL DRUGS AND BIRTH DEFECTS

While there are >30 antiretroviral (ARV) drugs approved for HIV therapy, there are only limited data on ARVs in pregnancy. The mean lag time from ARV approval to data availability in pregnancy is 5 years; most ARVs receive regulatory approval with only animal data to evaluate potential fetal effects. For low incidence outcomes such as…

CHASING THE DRAGON: OPIATES AND HIV

The opioid crisis is the first truly national drug epidemic in US history. Unlike prior drug use epidemics, the opioid crisis has reached all groups regardless of demographic characteristics, economic status, or geography. HIV-related consequences of the opioid crisis include increased injection drug use (still a key risk factor for HIV transmission), increased mixing of…

HIDDEN IN PLAIN SIGHT: THE ALCOHOL EPIDEMIC

Alcohol is widely used for pleasure by many cultures throughout the world except in Muslim-majority countries. Although it has also been credited with having some protective effect for some health outcomes, its abuse is highly problematic as it causes a large social and economic burden, both to individuals who consume it and other people close…